Your browser doesn't support javascript.
loading
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.
Blum, Kenneth; Braverman, Eric R; Gold, Mark S; Dennen, Catherine A; Baron, David; Thanos, Panayotis K; Hanna, Colin; Elman, Igor; Gondre-Lewis, Marjorie C; Ashford, J Wesson; Newberg, Andrew; Madigan, Margaret A; Jafari, Nicole; Zeine, Foojan; Sunder, Keerthy; Giordano, John; Barh, Debmayla; Gupta, Ashim; Carney, Paul; Bowirrat, Abdalla; Badgaiyan, Rajendra D.
Afiliación
  • Blum K; Division of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, California, United States of America.
  • Braverman ER; The Kenneth Blum Behavioral and Neurogenetic Institute LLC, Austin, Texas, United States of America.
  • Gold MS; Faculty of Education and Psychology, Institute of Psychology, Eötvös Loránd University Budapest, Budapest, Hungary.
  • Dennen CA; Department of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Baron D; Division of Personalized Medicine, Cross-Cultural Research and Educational Institute, San Clemente, California, United States of America.
  • Thanos PK; Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Purba Medinipur, West Bengal, India.
  • Hanna C; Division of Personalized Recovery Science, Transplicegen Therapeutics, Llc., Austin, Tx., United of States.
  • Elman I; Department of Psychiatry, University of Vermont, Burlington, Vermont, United States of America.
  • Gondre-Lewis MC; Department of Psychiatry, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America.
  • Ashford JW; Division of Personalized Medicine, Ketamine Clinic of South Florida, Pompano Beach, Florida, United States of America.
  • Newberg A; The Kenneth Blum Behavioral and Neurogenetic Institute LLC, Austin, Texas, United States of America.
  • Madigan MA; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Jafari N; Department of Family Medicine, Jefferson Health Northeast, Philadelphia, Pennsylvania, United States of America.
  • Zeine F; Division of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, California, United States of America.
  • Sunder K; Department of Psychology and Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University of Buffalo, Buffalo, New York, United States of America.
  • Giordano J; Department of Psychology and Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University of Buffalo, Buffalo, New York, United States of America.
  • Barh D; Cambridge Health Alliance, Harvard Medical School, Cambridge, Massachusetts, United States of America.
  • Gupta A; Department of Anatomy, Howard University School of Medicine, Washington, D.C., United States of America.
  • Carney P; Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California, United States of America.
  • Bowirrat A; Department of Integrative Medicine and Nutritional Sciences, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania, United States of America.
  • Badgaiyan RD; The Kenneth Blum Behavioral and Neurogenetic Institute LLC, Austin, Texas, United States of America.
INNOSC Theranostics Pharmacol Sci ; 7(2): 1472, 2024 Apr 30.
Article en En | MEDLINE | ID: mdl-38766548
ABSTRACT
The Carter Center has estimated that the addiction crisis in the United States (US), if continues to worsen at the same rate, may cost the country approximately 16 trillion dollars by 2030. In recent years, the well-being of youth has been compromised by not only the coronavirus disease 2019 pandemic but also the alarming global opioid crisis, particularly in the US. Each year, deadly opioid drugs claim hundreds of thousands of lives, contributing to an ever-rising death toll. In addition, maternal usage of opioids and other drugs during pregnancy could compromise the neurodevelopment of children. A high rate of DNA polymorphic antecedents compounds the occurrence of epigenetic insults involving methylation of specific essential genes related to normal brain function. These genetic antecedent insults affect healthy DNA and mRNA transcription, leading to a loss of proteins required for normal brain development and function in youth. Myelination in the frontal cortex, a process known to extend until the late 20s, delays the development of proficient executive function and decision-making abilities. Understanding this delay in brain development, along with the presence of potential high-risk antecedent polymorphic variants or alleles and generational epigenetics, provides a clear rationale for embracing the Brain Research Commission's suggestion to mimic fitness programs with an adaptable brain health check (BHC). Implementing the BHC within the educational systems in the US and other countries could serve as an effective initiative for proactive therapies aimed at reducing juvenile mental health problems and eventually criminal activities, addiction, and other behaviors associated with reward deficiency syndrome.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: INNOSC Theranostics Pharmacol Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: INNOSC Theranostics Pharmacol Sci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos